Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 1, 2007, Pages 16-21

  Miyamoto, Hiroshi ^a   Okahisa, Toshiya ^a   Iwaki, Hiroshi ^a   Murata, Masahiko ^a   Ito, Susumu ^a   Nitta, Yoshinori ^a   Akutagawa, Masatake ^a   Kinouchi, Yohsuke ^a   Ohnishi, Yoshiaki ^a   Oto, Jun ^a   Nishimura, Masaji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anemia; Cellsorba; Crit Line; Leukocytapheresis; Ulcerative colitis

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD FILTER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTAPHERESIS; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; HEART RATE; HEMATOCRIT; HEMODYNAMICS; HUMAN; INCIDENCE; LEUKAPHERESIS; MALE; MELENA; MONITOR; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; ULCERATIVE COLITIS;

ADULT; AGED; ANEMIA; COLITIS, ULCERATIVE; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HUMANS; LEUKAPHERESIS; MALE; MELENA; MIDDLE AGED;

EID: 33846943999     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00451.x     Document Type: Article

References (16)

1. Takagi H, Hibi T. Treatment of inflammatory intestinal diseases. J Med Pharm Sci 2004;52:531-9.
2. Sawada K, Muto T, Shimoyama T. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:307-21.
3. Kondoh T, Hidaka Y, Katoh H, Inoue N, Saito S. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Artif Organs 1991;15:180-8.
4. Sawada K, Ohnishi K, Kosaka T. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher 1997;1:207-11.
5. Nagase K, Sawada K, Ohnishi K, Fukunaga K, Shimoyama T. The evaluation of the loss rate of blood cells in ulcerative colitis patients during extracorporeal circulation therapy. Jpn J Apher 2000;19:51-5.
6. Ueki Y, Yamasaki S, Kanamoto Y. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology 2000;39:165-71.
7. Hidaka T, Suzuki K, Matsuki Y. Filtration leukocytapheresis therapy in rheumatoid arthritis. Arthritis Rheum 1999;42:431-7.
8. Suzuki K, Matsuki Y, Azuma T. The utility of lymphocytapheresis for the treatment of patients with malignant rheumatoid arthritis. Jpn J Soc Apher 1996;15:303-19.
9. Amano K, Amano K. Ulcerative colitis therapy with a leukocytapheresis. Tissue Cult Eng 1997;23:473-6.
10. Kosaka T, Sawada K, Ohnishi K. Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's Disease. Intern Med 1999;38:102-11.
11. Andoh A, Ogawa A, Kitamura K. Suppression of interleukin-1beta-and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol 2004;39:1150-7.
12. Munakata A. Diagnosis standard revision plan for ulcerative colitis. Annual report of the research committee of inflammatory bowel disease, The Ministry of Health and Welfare of Japan. 1998;96-99.
13. Yamaji K, Yang K, Tsuda H. Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Ther Apher 2002;6:402-12.
14. Sawada K, Kusugami K, Suzuki Y. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol 2005;100:1362-9.
15. Shibata H, Kuriyama T, Yamawaki N. Cellsorba. Ther Apher Dial 2003;7:44-7.
16. Iwasa C, Toba K, Endo T. Adverse reactions and its counterplans in filtration leukocytapheresis in patients with rheumatoid arthritis. Jpn J Apher 2000;19:46-50.